Literature DB >> 12418594

Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma.

A M Jones1, M Munavvar, A Vail, R E Aldridge, L Hopkinson, C Rayner, B R O'Driscoll.   

Abstract

BACKGROUND: The optimal duration of oral steroid treatment in the management of acute adult asthma is unclear. We prospectively studied the effect of 5 vs. 10 days of oral prednisolone in patients with acute asthma requiring hospital admission.
METHODS: Each patient received 40 mg of enteric-coated prednisolone daily for 5 days, followed by 5 days of 40 mg prednisolone daily (n=24) or placebo (n=20). All were given their usual inhaled asthma therapy including inhaled corticosteroids. Patients kept PEF and symptom diaries for 21 days.
RESULTS: For the 5-day treatment group mean (95% CI) early morning PEF was 6 (-47,+36) l/min lower to day 21 (P=0.78). There was no evidence of differences in other PEF measures (morning post-bronchodilator, evening or worst of day). One patient in each group had an exacerbation requiring further oral steroids during the 21-day observation period. Asthma symptom scores were worse in the 5-day group on days 6-21 but the significance of this finding was uncertain, as a difference had emerged by day 5 (prior to trial entry).
CONCLUSIONS: It may be possible to reduce the standard steroid course to 5 days in acute adult asthma, provided all patients receive inhaled steroids and a personal asthma management plan.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12418594     DOI: 10.1053/rmed.2002.1369

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

1.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

Review 2.  Asthma in adults.

Authors:  Rodolfo J Dennis; Ivan Solarte; Gustavo Rodrigo
Journal:  BMJ Clin Evid       Date:  2010-01-21

Review 3.  Asthma in adults (acute).

Authors:  Gustavo Rodrigo
Journal:  BMJ Clin Evid       Date:  2011-04-04

Review 4.  An umbrella review: corticosteroid therapy for adults with acute asthma.

Authors:  Jerry A Krishnan; Steven Q Davis; Edward T Naureckas; Peter Gibson; Brian H Rowe
Journal:  Am J Med       Date:  2009-11       Impact factor: 4.965

5.  Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D.

Authors:  C B Franco; G Paz-Filho; P E Gomes; V B Nascimento; C A M Kulak; C L Boguszewski; V Z C Borba
Journal:  Osteoporos Int       Date:  2009-03-20       Impact factor: 4.507

6.  COPD exacerbations in general practice: variability in oral prednisolone courses.

Authors:  Marianne de Vries; Annette J Berendsen; Henk E P Bosveld; Huib A M Kerstjens; Thys van der Molen
Journal:  BMC Fam Pract       Date:  2012-01-12       Impact factor: 2.497

Review 7.  Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.

Authors:  John Blakey; Li Ping Chung; Vanessa M McDonald; Laurence Ruane; John Gornall; Chris Barton; Sinthia Bosnic-Anticevich; John Harrington; Mark Hew; Anne E Holland; Trudy Hopkins; Lata Jayaram; Helen Reddel; John W Upham; Peter G Gibson; Philip Bardin
Journal:  Respirology       Date:  2021-09-29       Impact factor: 6.175

Review 8.  Corticosteroids in the treatment of acute asthma.

Authors:  Abdullah A Alangari
Journal:  Ann Thorac Med       Date:  2014-10       Impact factor: 2.219

Review 9.  Asthma Exacerbations: Pathogenesis, Prevention, and Treatment.

Authors:  Jamee R Castillo; Stephen P Peters; William W Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2017 Jul - Aug

Review 10.  Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System.

Authors:  Cindy Strehl; Lisa Ehlers; Timo Gaber; Frank Buttgereit
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.